We apologize if you were not able to log into this webinar due to an Adobe Connect server issue. Please note that the recording of this webinar is available below and will also be available as a Home Study course providing CE credit in a few weeks.
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, May 5, 2020, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: Nitrosamine Impurities in Drugs: What Health Care Professionals Need to Know. This educational activity provided an overview of nitrosamine impurities identified in several prescription and over-the-counter drug products. The presentation included background information on nitrosamines, a discussion of pharmaceutical quality, FDA's role in protecting the public, and an overview of public outreach and engagement as it relates to this issue.
View Presentation Here: https://collaboration.fda.gov/psp8381keomw/
Download Presentation Slides: Nitrosamine Impurities in Drugs (PDF - 1.34MB)
Activity Outline and Continuing Education Information: Nitrosamine Impurities in Drugs (PDF - 167KB)
If you have never attended an Adobe Connect meeting before:
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Resources For You